Armata Pharmaceuticals Profit Margin 2006-2021 | ARMP
Current and historical gross margin, operating margin and net profit margin for Armata Pharmaceuticals (ARMP) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Armata Pharmaceuticals net profit margin as of June 30, 2021 is -795.84%.
|Armata Pharmaceuticals Annual Profit Margins
|Armata Pharmaceuticals Quarterly Profit Margins
||Medical - Biomedical and Genetics
Armata Pharmaceuticals Inc. is a biotechnology company. It is focused on the development of bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. The company's principal product candidate consist AP-SA01, targets Staphylococcus aureus including multidrug-resistant strains. It is also developing and advancing a pipeline of synthetic phage candidates, including a synthetic phage for Pseudomonas aeruginosa. Armata Pharmaceuticals Inc., formerly known as AmpliPhi Biosciences Corporation, is based in Marina del Rey, California.